Literature DB >> 19104802

Combined PET/MRI: a new dimension in whole-body oncology imaging?

Gerald Antoch1, Andreas Bockisch.   

Abstract

INTRODUCTION: Hybrid imaging systems providing morphological and functional data in a single session have been available for oncological imaging for some time. So far, computed tomography (CT) has been the morphological method-of-choice for inclusion into these hybrid imaging systems. However, recently, research has focused on hardware-based fusion of function with magnetic resonance imaging (MRI) rather than CT.
OBJECTIVES: Now that the first head-only positron emission tomography (PET)/MRI systems have been installed and whole-body systems are to be expected in the near future, potential indications in clinical oncology have to be addressed. DISCUSSION: This article discusses potential indications of PET/MRI in whole-body oncology imaging. Potential advantages and disadvantages compared with currently available hybrid imaging systems will be reviewed.

Entities:  

Mesh:

Year:  2009        PMID: 19104802     DOI: 10.1007/s00259-008-0951-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  37 in total

Review 1.  Whole-body MR imaging. Practical issues, clinical applications, and future directions.

Authors:  S J Eustace; R Walker; M Blake; E K Yucel
Journal:  Magn Reson Imaging Clin N Am       Date:  1999-05       Impact factor: 2.266

2.  To TOF or not to TOF: strategies for non-contrast-enhanced intracranial MRA at 7 T.

Authors:  Stefan Maderwald; Susanne C Ladd; Elke R Gizewski; Oliver Kraff; Jens M Theysohn; Karsten Wicklow; Christoph Moenninghoff; Isabel Wanke; Mark E Ladd; Harald H Quick
Journal:  MAGMA       Date:  2008-01-04       Impact factor: 2.310

Review 3.  A review of cranial imaging techniques: potential and limitations.

Authors:  Rudolf Fahlbusch; Amir Samii
Journal:  Clin Neurosurg       Date:  2007

Review 4.  Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging?

Authors:  Bernd J Pichler; Hans F Wehrl; Armin Kolb; Martin S Judenhofer
Journal:  Semin Nucl Med       Date:  2008-05       Impact factor: 4.446

5.  Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy.

Authors:  C A Staples; N L Müller; R R Miller; K G Evans; B Nelems
Journal:  Radiology       Date:  1988-05       Impact factor: 11.105

6.  Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F-FDG PET/CT.

Authors:  S Pauls; A K Buck; K Hohl; G Halter; M Hetzel; N M Blumstein; F M Mottaghy; G Glatting; S Krüger; L Sunder-Plassmann; P Möller; V Hombach; H-J Brambs; S N Reske
Journal:  Nuklearmedizin       Date:  2007       Impact factor: 1.379

7.  Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.

Authors:  L S Freudenberg; A O Schueler; T Beyer; G Antoch; H Kühl; N Bornfeld; A Bockisch; T Egelhof
Journal:  Surv Ophthalmol       Date:  2004 Sep-Oct       Impact factor: 6.048

8.  Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer.

Authors:  L S Freudenberg; G Antoch; W Jentzen; R Pink; J Knust; R Görges; S P Müller; A Bockisch; J F Debatin; W Brandau
Journal:  Eur Radiol       Date:  2004-06-30       Impact factor: 5.315

9.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.

Authors:  Gerald Antoch; Florian M Vogt; Lutz S Freudenberg; Fridun Nazaradeh; Susanne C Goehde; Jörg Barkhausen; Gerlinde Dahmen; Andreas Bockisch; Jörg F Debatin; Stefan G Ruehm
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

Review 10.  PET/CT in oncology: for which tumours is it the reference standard?

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more
  71 in total

1.  An MR image-guided, voxel-based partial volume correction method for PET images.

Authors:  Hesheng Wang; Baowei Fei
Journal:  Med Phys       Date:  2012-01       Impact factor: 4.071

2.  [Functional and molecular imaging of breast tumors].

Authors:  K Pinker; P Brader; G Karanikas; K El-Rabadi; W Bogner; S Gruber; M Reisegger; S Trattnig; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

Review 3.  Review of functional/anatomical imaging in oncology.

Authors:  Stephanie N Histed; Maria L Lindenberg; Esther Mena; Baris Turkbey; Peter L Choyke; Karen A Kurdziel
Journal:  Nucl Med Commun       Date:  2012-04       Impact factor: 1.690

4.  Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.

Authors:  Michael Souvatzoglou; Matthias Eiber; Toshiki Takei; Sebastian Fürst; Tobias Maurer; Florian Gaertner; Hans Geinitz; Alexander Drzezga; Sibylle Ziegler; Stephan G Nekolla; Ernst J Rummeny; Markus Schwaiger; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-02       Impact factor: 9.236

Review 5.  PET/MR in prostate cancer: technical aspects and potential diagnostic value.

Authors:  Michael Souvatzoglou; Matthias Eiber; Axel Martinez-Moeller; Sebastian Fürst; Konstantin Holzapfel; Tobias Maurer; Sibylle Ziegler; Stephan Nekolla; Markus Schwaiger; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-24       Impact factor: 9.236

6.  Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer.

Authors:  K Kubiessa; S Purz; M Gawlitza; A Kühn; J Fuchs; K G Steinhoff; A Boehm; O Sabri; R Kluge; T Kahn; P Stumpp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-29       Impact factor: 9.236

7.  MRI-based nonrigid motion correction in simultaneous PET/MRI.

Authors:  Se Young Chun; Timothy G Reese; Jinsong Ouyang; Bastien Guerin; Ciprian Catana; Xuping Zhu; Nathaniel M Alpert; Georges El Fakhri
Journal:  J Nucl Med       Date:  2012-06-28       Impact factor: 10.057

8.  A Comparison of 18F-FDG-PET/MRI and 18F-FDG-PET/CT in the Cancer Staging of Locoregional Lymph Nodes.

Authors:  David Slouka; Jiri Krcal; Tomas Kostlivy; Petr Hrabacka; Alena Skalova; Hynek Mirka; Ondrej Topolcan; Radek Kucera
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

9.  Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.

Authors:  Michael A Jacobs; Katarzyna J Macura; Atif Zaheer; Emmanuel S Antonarakis; Vered Stearns; Antonio C Wolff; Thorsten Feiweier; Ihab R Kamel; Richard L Wahl; Li Pan
Journal:  Acad Radiol       Date:  2018-04-04       Impact factor: 3.173

Review 10.  Imaging of distant metastases of prostate cancer.

Authors:  Filippo Pesapane; Marcin Czarniecki; Matteo Basilio Suter; Baris Turkbey; Geert Villeirs
Journal:  Med Oncol       Date:  2018-09-14       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.